Nebenwirkungen · Bortezomib Accord
Bortezomib Accord 1 mg powder for solution for injection Bortezomib Accord 3.5 mg powder for solution for injection · Abschnitt 4.8 · PDF-Seite 54–55
HOS-133340 · Präparat HOS-097412
54 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was administered in 130 patients with relapsed multiple myeloma, who previously had at least partial response on a bortezomib-containing regimen, the most common all-grade adverse reactions occurring in at least 25% of patients were thrombocytopenia (55%), neuropathy (40%), anaemia (37%), diarrhoea (35%), and constipation (28%). All grade peripheral neuropathy and grade ≥ 3 peripheral neuropathy were observed in 40% and 8.5% of patients, respectively.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-25T15:00:00Z · SHA-256 95954b33292c291c1f0b9499f65ea0d9efd1266892e12a142f48541fdf5605bb · Passage a95e8dc51aabc6ba7ea769bad89c390b7c063579e9df60e2f7bb2c1d27d20f3a · Zeichen 31351–31908 im Abschnitt